Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene polymorphisms associated with progression of primary open-angle glaucoma: A systematic review. | Surv Ophthalmol | 2026 | 42754173 | PubTator, text mining | PubMed |
| RUNX3: a regulator of macrophage apoptosis with positive prognostic impact in sepsis. | Genes Genomics | 2026 | 42742904 | PubTator, text mining | PubMed |
| Interleukin-1α Mediates Pancreatic Fibroblast Activation, Regulates Immune Cell Recruitment and Fibrosis in Acute and Chronic Pancreatitis. | Adv Sci (Weinh) | 2026 | 42693602 | PubTator, text mining | PubMed |
| Three-dimensional primary myofibroblast culture reveals morphological alterations in CPAMD8 deficiency. | Exp Eye Res | 2026 | 42692183 | PubTator, text mining | PubMed |
| TGFBR3 regulates the expression of FATP2-ACSL1 axis related proteins and accompanies changes in the migration and invasion ability of lung cancer cells. | Front Oncol | 2026 | 42656625 | PubTator, text mining | PubMed |
| Shifting the balance: expression of transforming growth factor β receptor subunit genes in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate. | J Physiol Pharmacol | 2026 | 42533456 | PubTator, text mining | PubMed |
| Kinome-wide CRISPR/Cas9-knockout screening reveals critical protein kinases in vasopressin V2-receptor signaling. | bioRxiv | 2026 | 42465376 | PubTator, text mining | PubMed |
| Heparan Sulfate Proteoglycans in Immunity. | Proteoglycan Res | 2026 | 42383138 | PubTator, text mining | PubMed |
| Acute exercise shifts inferred immune cell composition and cytotoxic gene programs in pediatric sickle cell anemia. | 3 Biotech | 2026 | 42375599 | PubTator, text mining | PubMed |
| Placental plasminogen activator inhibitor 1 is induced by platelet-derived TGF-β independently of TGF-β receptor 3 and is upregulated in preeclampsia. | Mol Hum Reprod | 2026 | 42371787 | PubTator, text mining | PubMed |
| GLIS3 drives epithelial-mesenchymal transition and cancer stem-like traits in stomach adenocarcinoma via TGFBR3-Hedgehog signaling. | Front Oncol | 2026 | 42255230 | PubTator, text mining | PubMed |
| Human PRSS8 functions as a targetable, endogenous TGFBR3 sheddase via the novel cholesterol-PRSS8-TGF-β axis. | Biochem Biophys Res Commun | 2026 | 42184470 | PubTator, text mining | PubMed |
| The Exosomal miR-130b-5p Derived From Crohn's Disease-Associated Mesenteric Adipose Tissue Promotes Ileocolonic Anastomotic Fibrosis via the Smad Signaling Pathway. | FASEB J | 2026 | 42068215 | PubTator, text mining | PubMed |
| The TMPO-AS1/hsa-let-7b-5p regulatory axis shapes transcriptional heterogeneity and immune landscape in lung adenocarcinoma. | Cell Div | 2026 | 41975423 | PubTator, text mining | PubMed |
| Integrative Single-Cell and Machine Learning Analysis Identifies an EMT-Associated Prognostic Signature for Papillary Thyroid Cancer. | Cancer Med | 2026 | 41957879 | PubTator, text mining | PubMed |
| A Cross-Tissue Multiomics Analysis Reveals the Protective Role of TGFBR3 in Postmenopausal Osteoporosis. | Int J Genomics | 2026 | 41948101 | PubTator, text mining | PubMed |
| MicroRNA Regulation in Kidney Interstitial Fibrosis. | Epigenomes | 2026 | 41892370 | PubTator, text mining | PubMed |
| Exploring TGFBR3 in disease pathogenesis: Mechanisms, clinical implications, and pharmacological modulation. | J Pharm Anal | 2026 | 41890823 | PubTator, text mining | PubMed |
| Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization. | NPJ Cardiovasc Health | 2026 | 41882153 | PubTator, text mining | PubMed |
| RUNX1 restrains STAT1-GITRL signaling to shape an immunosuppressive CRC microenvironment. | Cell Death Discov | 2026 | 41881966 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers